Smeykal Megan

Chief Accounting OfficerTELA Bio, Inc. (TELA) · full profile →Form 4 · filed Feb 24, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 23, 2026Tax withholding(F)423$0.77$32667K
Feb 21, 2026Tax withholding(F)2K$0.72$1K67K
Feb 19, 2026Tax withholding(F)795$0.80$63669K
Feb 18, 2026Grant(A)33K$070K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001899973-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: